Purpose: The purpose of the study was to evaluate the role of intravoxel incoherent motion (IVIM) diffusion model for the assessment of liver fibrosis and inflammation in diffuse liver disorders, also considering the presence of liver steatosis and iron deposits. Methods: Seventy-four patients were included, with liver biopsy and a 3 Tesla abdominal magnetic resonance imaging examination, with an IVIM diffusion-weighted sequence (single-shot spin-echo echo-planar sequence, with gradient reversal fat suppression; 6 b-values: 0, 50, 200, 400, 600, and 800 s/mm 2 ). Histological evaluation comprised the Ishak modified scale, for grading inflammation and fibrosis, plus steatosis and iron loading classification. The liver apparent diffusion coefficient (ADC) and IVIM parameters (D, D*, f) were calculated from the IVIM images. The relationship between IVIM parameters and histopathological scores were evaluated by ANOVA and Spearman correlation tests. A testretest experiment assessed reproducibility and repeatability in 10 healthy volunteers and 10 randomly selected patient studies. Results: ADC and f values were lower with higher fibrosis stages (p = 0.009, p = 0.006, respectively) and also with higher necro-inflammatory activity grades (p = 0.02, p = 0.017, respectively). Considered together, only fibrosis presented a significant effect on ADC and f measurements (p < 0.05), whereas inflammation had no significant effect (p > 0.05). A mild correlation was found between ADC and f with fibrosis (R S = -0.32 and R S = -0.38; p < 0.05) and inflammation (R S = -0.31 and R S = -0.32, p < 0.05; respectively). The AUROC for ADC and f measurements with the different dichotomizations between fibrosis or inflammation grades were only fair (0.670 to 0.749, p < 0.05). Neither D nor D* values were significantly different between liver fibrosis or inflammation grades. D measurements were significantly different across histologic grades of steatosis (p < 0.001) and iron overload (p < 0.001), whereas f measurements showed significant differences across histologic steatosis grades (p = 0.005).
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Correspondence to: Manuela Franc¸a; email: mariamanuela.franca@ gmail.com Diffuse liver diseases are related to a wide spectrum of etiologies, such as viral hepatitis infection, alcohol and drug consumption, fatty liver, auto-immune and metabolic diseases, leading to longstanding liver damage and inflammatory reaction, and finally triggering fibrosis with extracellular sinusoidal accumulation of collagens, proteoglycans and macromolecules. Patients with liver inflammation and fibrosis may remain asymptomatic, being important to promptly and reliably detect and grade both conditions to start treatment early enough [1] . Although liver biopsy is still considered the gold standard for the evaluation of liver fibrosis and inflammation, its use is declining, as the technique is invasive and might not be safe for the patient [2] . Furthermore, biopsy has accuracy limitations related to the large sampling bias and high inter-and intra-observer variability reports [3] . Consequently, there is a need to evaluate noninvasive biomarkers for diagnosing and staging the whole liver inflammatory injury and fibrosis status.
Diffusion-weighted (DW) magnetic resonance (MR) imaging has been proposed as a tool to assess liver inflammation and fibrosis [4] [5] [6] [7] [8] [9] . Apparent diffusion coefficient (ADC), derived from the monoexponential fitting model, is heavily influenced by the b-value choice and it is influenced not only by the diffusion of water in the extracellular space but also by the capillary blood perfusion [10] . The bi-exponential intravoxel incoherent motion (IVIM) DW model [11, 12] allows separating the diffusion and perfusion effects by quantifying the pure diffusion coefficient (D), the pseudo-diffusion (D*), and vascular fraction (f) microperfusion parameters. Lower ADC values in liver with fibrosis were associated to both liver compartment restrictions [13] [14] [15] [16] . Other authors found lower ADC values in fibrotic livers being only dependent on perfusion parameters changes [5, 17, 18] . Liver inflammation is characterized by different grades of hepatocytes' swelling and necrosis, inflammatory cells migration through liver sinusoids and increased regional blood flow [19] . Inflammatory responses may also influence ADC measurements [6, 7, 9, [20] [21] [22] and both diffusion and perfusion IVIM parameters.
The presence of concomitant fat and iron deposits in the liver parenchyma might also affect water diffusion and the derived biomarkers [23] [24] [25] [26] [27] . Moreover, the DW sequence, performed with an echo-planar imaging technique, is prone to susceptibility artifacts induced by iron deposits [23] . The possible interaction and confounding effects of liver inflammation, fibrosis, fat and iron deposits in the IVIM parameters have not been previously addressed in diffuse liver diseases.
Our objective was to evaluate the diagnostic accuracy of IVIM parameters for the detection and staging of both liver fibrosis and inflammation, considering the different clinical scenarios of diffuse liver disorders, and taking into consideration the effects of steatosis and iron overload.
Patients and methods

Study design and population
The Institutional Review Board approved this prospective, comparative, non-randomized single center study.
Between April 2013 and January 2014, all adult patients referred for liver biopsy were invited to participate in this study, except those with contra-indications to MR examination. Over these 10 months, 88 patients were recruited after obtaining written informed consent from them. Since severe iron overload lowers the liver signal intensity on MR images, patients with known hemochromatosis were excluded (n = 8). Six patients were afterwards excluded due to MR imaging movement artifacts (n = 3), malignancy within the biopsy sample (n = 2) and claustrophobia (n = 1). The final series included 74 patients (Fig. 1) .
To check for MR reproducibility and repeatability, 10 healthy volunteers with no liver disease were also collected and evaluated with the same MR sequences.
Liver biopsy
One percutaneous biopsy sample per patient was obtained under ultrasound guidance, using 16-18G needles. Patients with focal liver lesions and suspected of having diffuse liver disease underwent a second targeted biopsy for the lesion. Although most biopsies were sampled from the right anterior segments, the Couinaud segmentation was registered to locate the regions of interest (ROIs) at the MR images. In cases of patients that underwent liver biopsy after the MR examination (10 patients), the liver biopsy was performed blinded to MR evaluation and the MR imaging analysis and ROI measurements were performed after biopsy.
Histological evaluation
Histological evaluation of biopsy samples was considered the reference standard for the prospective assessment and grading of liver inflammation and fibrosis, steatosis and iron deposits.
One pathologist (SG, 9 years' experience), blinded to the MR results, verified the quality of the specimens and evaluated the liver samples using hematoxylin-eosin, Masson's trichrome, and Perls' Prussian stains. The Ishak modified scale was used for grading inflammation (0-18) and fibrosis (F0-F6) [28] . Hepatic steatosis was estimated according to the proportion of hepatocytes containing fat vesicles: no steatosis (grade 0, less than 5%); mild steatosis (grade 1, 5% to 33%); moderate steatosis (grade 2, 33% to 66%); and severe steatosis (grade 3, more than 66%) [29] . Iron loading was scored using a five grading system (0: no iron overload to 4: severe overload) [30] .
MR imaging examination
Mean time interval between biopsy and MR examination was 2 days (range 0-25 days), most patients (77%) being examined in the same day of liver biopsy.
MR scans were performed in a 3 Tesla system (3T-TX Achieva, Philips Healthcare, The Netherlands), with a sixteen-channel phased-array coil. The liver MR imaging protocol included transverse T2-weighted turbo spin-echo sequence (TR/TE 850/80 ms, matrix 560, field of view 400 9 285 9 260 mm, slice thickness 5 mm, number of slices 35), coronal transverse T2-weighted turbo spin-echo sequence (TR/TE 1170/80 ms, matrix 448, field of view 375 9 448 9 158 mm, slice thickness 4 mm, number of slices 35), 2D multiecho chemical shift encoded gradient echo sequence (12 echoes, TE's = 0.99-8.69, echo spacing = 0.7 ms; TR = 10 ms; flip angle 10°; voxel dimensions, 3 9 3 mm; slice thickness, 7 mm; 0.3 mm gap; field of view, 375 9 302 mm, single breath-hold acquisition) and transverse IVIM DW imaging sequence. IVIM imaging was performed using a single-shot spin-echo echoplanar sequence (SE-EPI), with gradient reversal fat suppression, using 6 b-values (0, 50, 200, 400, 600, and 800 s/ mm 2 ) to maximize information in a reasonable time frame, and the following parameters: TR/TE 2205/74 ms, echoplanar imaging factor 63, FOV 375 9 305 9 207 mm, slice thickness 7 mm, matrix 256, receiver bandwidth 2000 Hz per pixel, number of slices 27, number of signals averaged 2, parallel imaging (accelerating factor 2) and respiratory-triggered acquisition. The scan duration was about 10 min.
Image analysis
Images were exported as raw data to calculate liver apparent diffusion coefficient (ADC) and IVIM parameters using QUIBIM research analysis platform (Valencia, Spain). Images from the different b-values were spatially registered using b = 0 as the reference. The ADC was calculated by a monoexponential fitting using all of b-values. The pure D and perfusion-related D* and f parameters were obtained using the biexponential fitting [12] .
One radiologist (MF, 8 years' experience) reviewed the images blinded to the histological results and clinical status. Three ROIs, 5 mm diameter, were manually placed in the right lobe and within the biopsied liver segment. ROIs were drawn in b-value = 0 and the coordinates of the voxels within the ROI were used to extract the values from the parametric maps. Care was taken to avoid blood vessels, focal lesions, motion artifacts, regions with poor signal to noise and biopsy tracts. For each ROI, the analysis was performed voxelwise and all the histogram was considered, the average of the three ROIs' values being used for statistical analysis as the dependent MR derived variables.
Reproducibility and repeatability tests
A test-retest experiment was designed to assess reproducibility and repeatability. Ten healthy volunteers (4 men, 6 women; mean age 33 years) were scanned with the same MR protocol as the patients. The MR examina- tions were performed on two separate occasions, within different sessions at the same day. Three blinded observers (MF, radiologist with 8 years' experience; JO, radiologist in the forth training year; JA, radiologist in the second training year) separately and independently evaluated the acquired images, placing 4 different ROIs in the right liver lobe.
In order to further assess intra-observer reproducibility, 10 randomly selected patients, with different grades of fibrosis and inflammatory activity, were assessed by re-reading the studies on a second separate occasion, by the same observer (MF).
Statistical analysis
Descriptive statistics were used to summarize the patients' characteristics. Categorical variables were evaluated by v 2 and Fisher's exact test. For statistical analysis, necro-inflammatory activity score was grouped as none (score 0), mild (scores 1-6), moderate (scores 7-12), and severe inflammation (scores [13] [14] [15] [16] [17] [18] . The Ishak fibrosis staging was categorized into none (F0), mild to moderate fibrosis (F1-F3), and marked fibrosis/cirrhosis (F4-F6). Steatosis was grouped as none (grade 0), mild (grade 1) and significant steatosis (grade 2-3). Iron grades were categorized as none (grade 0), mild (grade 1), and moderated to severe siderosis (grade 2-4).
Differences in ADC, D, D*, and f measurements across the categorical histologic grades of liver inflammation, fibrosis, steatosis or iron deposits were assessed with one-way analysis of variance, with post hoc Tukey HSD test. The Kruskal-Wallis test, with post hoc MannWhitney test and Bonferroni correction, was used when the variances were non-homogeneous, as was the case of f values across different grades of steatosis. Factorial analysis of variance was performed to evaluate the joint effect of fibrosis and inflammation. The Spearman correlation coefficient was used to calculate the degree of association between continuous and/or ordinal variables. Receiver operating characteristic (ROC) analysis evaluated the measurements' diagnostic performance. The area under the ROC curve (AUROC) was calculated for each set of dichotomized groups of histological grades of fibrosis (F0 vs. F1 or higher; F0-F3 vs. F4-F6) and necro-inflammatory activity (grade 0 vs. 1 or higher; grade 6 or lower vs. 7 or higher).
For measurements in volunteers, the agreement between the readers was assessed by intra-class correlation coefficients (ICCs) with 95% confidence intervals for the average values on each acquisition. Repeatability was evaluated between the first and second acquisitions in volunteers.
SPSS (version 22; SPSS, IBM, Chicago, Ill) was used for analysis. For all tests, a two-tailed p value of less than 0.05 was considered statistically significant.
Results
There were 74 patients in the final study population, including 38 men and 36 women, with a mean age of 46.4 years (standard deviation, 14.0; range of 19-77 years). The clinical indications for liver core biopsies were varied, including liver graft dysfunction (n = 23), persistent elevation of liver enzymes (n = 17), chronic HCV infection (n = 11), chronic alcoholic liver disease (n = 5), chronic HBV infection (n = 5), assessment of liver parenchyma during investigation of primary malignant focal liver lesion (n = 3), auto-immune hepatitis (n = 3), non-alcoholic fatty liver disease (n = 3), Wilson disease (n = 3), and toxic hepatitis (n = 1).
Histological results
All patients had adequate size biopsies (more than 15 mm in size). The stages of fibrosis and grades of necro-inflammatory activity, steatosis, and siderosis observed on histological analysis are summarized in Table 1 .
Only 4 patients (5%) did not have liver fibrosis or necro-inflammatory activity. None of the patients had severe liver inflammation. Twenty-eight (37.8%) patients had neither liver steatosis nor iron overload, while 46 (62.2%) patients had both fat and iron liver deposition within the sample. The grades of steatosis and siderosis, the stage of fibrosis, and the score of necro-inflammatory activity were not significantly associated (Fisher's exact test, p > 0.05).
Liver ADC and IVIM measurements
The ADC, D, D*, and f measurements are summarized in Table 2 . These biomarkers are shown accordingly to the hepatic fibrosis stage and necro-inflammatory activity, and also to the steatosis and siderosis grades.
Liver fibrosis and inflammation
ADC and f values showed significant differences (p = 0.009, p = 0.006, respectively) across fibrosis stages ( Fig. 2 ; Table 2 ): increasing stages of fibrosis showed lower ADC (R S = -0.32, p < 0.05) and f values (R S = -0.38, p < 0.05). Using Tukey HSD test, ADC and f measurements were only significantly different between patients with severe fibrosis or cirrhosis (F4-F6) and patients without fibrosis (F0) (p < 0.05). Calculated ADC and f values were also different across histologic grades of liver inflammation (p = 0.02 and p = 0.017, respectively) ( Fig. 3; Table 2 ). Using post hoc analysis, the ADC and f values were only significantly different between patients with moderate inflammation and patients without inflammation (p < 0.05), but were not significantly different between patients with none or mild inflammation (p > 0.05). ADC and f measurements had weak correlations with liver necro-inflammatory activity grading (R S = -0.31, p < 0.05; R S = -0.32, p < 0.05; respectively).
Neither the D nor the D* values were significantly different across groups of liver fibrosis or inflammation (p > 0.05).
Since the ADC and f measurements were both affected by liver fibrosis and inflammation, we evaluated their joint effect with Factorial Analysis of Variance (dependent variable: ADC and IVIM parameters; factors: histological categorical variables-inflammation and fibrosis). The interaction effect between inflammation and fibrosis was not significant (p = 0.748); thus, it was removed from the univariate model. Considering the main effects of both inflammation and fibrosis, fibrosis presented a significant effect on ADC (p = 0.032) and f measurements (p = 0.031), whereas inflammation had no significant effect neither on ADC (p = 0.124) nor f measurements (p = 0.137) (Fig. 4) .
The accuracy of ADC or f measurements to discriminate the different stages of fibrosis or the necro-inflammatory activity grades was only fair. To distinguish between patients without fibrosis (F0) from patients with fibrosis (F1 or higher), the AUROC for ADC and f measurements were 0.670 and 0.740 (p < 0.05), respectively. To distinguish between patients without or mild fibrosis (F0-F3) from patients with severe fibrosis and cirrhosis (F4-F6), the AUROC for ADC and f values were 0.705 and 0.690 (p < 0.05), respectively. To differentiate patients without inflammation (score 0) from patients with necro-inflammatory activity (score 1 or higher), the AUROC for ADC and f values were 0.748 and 0.749 (p < 0.05), respectively. To distinguish patients with none or minor (scores 0-6) from moderate inflammatory activity (scores 7-12), the AUROC for ADC and f values were 0.682 and 0.687 (p < 0.05), respectively.
Hepatic steatosis and siderosis
Calculated D measurements were significantly different across the histologic grades of steatosis (p < 0.001) and iron overload (p < 0.001), whereas f measurements showed significant differences only across histologic steatosis grades (Kruskal-Wallis, p = 0.005) (Fig. 5) . Patients with increased fat deposition showed lower D values (R S = -0.44, p < 0.001) and higher f values (R S = 0.42, p < 0.001). However, the mean f value of grade 1 steatosis group (0.37) was higher than grade 0 group (0.30) and grade 2 group (0.35) ( Table 2) . The D values were negatively correlated with iron overload (R S = -0.36, p = 0.002).
There were no significant differences on the ADC and D* values among histologic grades of liver steatosis or siderosis (p > 0.05).
Unfortunately, the number of patients in this study did not allow a multivariate analysis to test for all the interactions between the different categorical histologic variables in ADC or IVIM measurements.
Reproducibility of DW measurements
The median, IQR for ADC and IVIM values of healthy volunteers are presented in Table 3 Regarding the test-retest examination of 10 volunteers, there was an excellent agreement between the different readers for the measurements of ADC, D and f, and a fair agreement for the D* measurements. The reproducibility between the two different MR examinations was good for the ADC measurements (ICC > 0.8, p < 0.05) and excellent for the D and f estimated values (ICC > 0.86, p < 0.05). However, for the D* measurements, there was no agreement between measurements from the two different examinations (p > 0.05).
The intra-reader variability in the 10 patients was assessed by the ICCs between measurements performed on two different occasions. The intra-reader ICC on volunteers was excellent (ICC > 0.91, p < 0.05) for the ADC and all IVIM measurements. Furthermore, the intra-reader ICC in 10 patients was excellent for all of the MR measurements (ICC > 0.92, p < 0.001).
Discussion
We report that ADC and f values were lower with higher fibrosis stages, in patients with diffuse liver diseases. However, the correlation between these MR measurements and fibrosis stages was weak and the accuracy of ADC or f measurements to discriminate the different stages of fibrosis or the necro-inflammatory activity grades was only fair.
Several studies have associated reduced liver ADC measurements with liver fibrosis and cirrhosis [4, 6-9, 13, 17, 20-22, 31, 32] . ADC measurements contain both diffusion and perfusion components, which difficult the biological interpretation of reduced ADC values. The IVIM model allows separating the liver signal intensity changes due to true molecular diffusion from those related to perfusion within the tissue. Recently, it has been proposed that the IVIM model, and particularly the perfusion-related parameters D* and f, would be more advantageous to evaluate liver fibrosis than conventional ADC measurements [5, [13] [14] [15] [16] [17] [18] [33] [34] [35] . However, the influence of liver inflammation, steatosis and siderosis on liver values has to be considered in this analysis.
Initial studies showed that D* values measurements were lower in patients with cirrhosis than in non-cirrhotic patients [5] . However, other studies observed lower D, D* and f values in patients with cirrhosis compared to non-cirrhotic patients [33] , and lower f and D* values in patients with severe fibrosis (METAVIR ‡F3) [17] . Lower D, D*, and f values were observed with increasing stages of liver fibrosis in patients studied at 1.5 and 3 Tesla magnets [13, 14] . Three different animal studies reported contradictory results. Chow et al. [16] observed lower D and D* values with increasing liver fibrosis. Zhang et al. [18] observed that f values decreased with increasing fibrosis stage; however, they did not assess D* parameter. Finally, Hu et al. [15] observed inverse correlations between fibrosis stages and D, D*, and f measurements. Unluckily, none of these animal studies evaluated the influence of necro-inflammatory activity, fat or iron on IVIM parameters.
Our findings of diminished ADC and f values with increasing fibrosis support the previously reported perfusion-related association. As ADC measurements contain both diffusion and perfusion components, the different results for ADC and D values might be explained by changes in the liver perfusion rather than pure diffusion of water molecules restriction. These findings most probably reflect the accumulation of collagen deposits, which increases the hepatic resistance to portal blood flow and reduces the portal perfusion within the liver.
Inflammatory changes, such as cell necrosis and inflammatory cell infiltration within the sinusoids, might also influence DW signal. It has been reported that ADC and f values decreased not only with fibrosis stage [4-9, 13, 17, 20-22, 31-33] but also with the severity of necroinflammatory activity [6, 7, 9, [20] [21] [22] . However, in our series, only fibrosis was the main explicative variable for the ADC and perfusion-related f decrements.
Although we found differences across grades of inflammation and fibrosis with ADC and f measurements, only a mild correlation was discovered between the histological grades and MR measurements. Moreover, the AUROC that evaluate dichotomized fibrosis stages or inflammatory grades were fair, under 0.8. Thus, neither the ADC nor the f measurements demonstrated adequate accuracy to discriminate between different stages of liver fibrosis or grades of inflammatory activity. Therefore, the observed differences do not allow for an appropriate staging of fibrosis and inflammation pathological markers.
Imaging biomarkers might also be influenced by confounding factors such as fat or iron deposits, which are frequently present in diffuse liver diseases. We observed that pure D decreased with increasing grades of steatosis, similar with previous reports [24, 27, 34, 35] . Steatosis decrease water molecules movement due to the enlarged hepatocytes, overloaded with macrovesicles of fat, restricting both intracellular and extracellular diffusion [24] . Furthermore, the f measurements were influenced by fat deposition, increasing with the grade of liver steatosis. Steatosis may have a confounding effect in f measurements. The mean f values of grade 1 steatosis group (0.37) were higher than grade 0 (0.30) and grade 2 (0.35) groups, which might be explained by the effect of fibrosis, inflammation and steatosis in f measurements. Unfortunately, as previously mentioned, the number of patients in this study did not allow a multivariate analysis to test for all the interactions between the different categorical histologic variables in ADC or IVIM measurements.
Only the D values were significantly reduced by iron deposits, decreasing with the severity of overload. These values decreased mainly due to the signal decay and noise floor effects induced by the susceptibility effects of iron overload [23, 36] .
Regarding D* measurements, they were not related to the stage of liver fibrosis or inflammation and, quite important, they were not consistent between different MR examinations in volunteers.
This study has some limitations. We used 6 different b-values, a lower number than some previous studies. Nevertheless, there is no consensus about the ideal number of b-values that should be used and, moreover, it has been demonstrated the feasibility of IVIM analysis of DW images using a number of b-value as low as 4 [17, 37] . We have assessed test-retest reproducibility in volunteers and not in patients with liver diseases; the obtained results from normal tissue might not be adequately extrapolated to diseased livers [38] . There were relatively fewer patients with severe steatosis or siderosis scores, and no patient with severe inflammation, which might have limited the statistical significance of the results and have hampered the performance of factorial analyses with all the variables together. Another limiting factor is that the MR images and the histological results were analyzed by only one reader and, therefore, variability of both these results could not be assessed. ROIs were drawn in the same liver segment than liver biopsy to minimize the effect of the heterogeneously distributed diffuse liver damage. As most MR examinations were performed after liver biopsy, care was taken to avoid the biopsy tract although unrecognized hemorrhage or edema might have influenced MR results. Also, Ishak score is not a continuous scale and the increase of fibrous tissue accumulation or necro-inflammatory activity from one grade to another is not linear [39] . However, even with this limitations, liver biopsy is still considered the best reference standard. Although larger scale studies should validate the relationship between ADC and IVIM parameters and different degrees of fibrosis and inflammation, to definitively evaluate the interactions of different histologic variables on IVIM parameters, we believe that after our study the role of IVIM is limited in routine clinical practice and patient's outcome evaluation.
In conclusion, in spite of the differences in ADC and f derived IVIM values across different groups of liver fibrosis and inflammation, these metrics cannot properly discriminate between different stages of fibrosis or inflammation in different diffuse liver diseases. Steatosis may confound the f measurements. D* and D parameters are not useful biomarkers of liver fibrosis: D* is not a reproducible measure and D measurements are influenced by confounders such as fat and iron, which commonly coexist with liver fibrosis.
